BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24554667)

  • 1. Boosting functional avidity of CD8+ T cells by vaccinia virus vaccination depends on intrinsic T-cell MyD88 expression but not the inflammatory milieu.
    Hu Z; Wang J; Wan Y; Zhu L; Ren X; Qiu S; Ren Y; Yuan S; Ding X; Chen J; Qiu C; Sun J; Zhang X; Xiang J; Qiu C; Xu J
    J Virol; 2014 May; 88(10):5356-68. PubMed ID: 24554667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Signature of Enhanced Functional Avidity CD8
    Hu Z; Zhu L; Wang J; Wan Y; Yuan S; Chen J; Ding X; Qiu C; Zhang X; Qiu C; Xu J
    Sci Rep; 2017 Feb; 7():41558. PubMed ID: 28155878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adaptor molecule MyD88 directly promotes CD8 T cell responses to vaccinia virus.
    Zhao Y; De Trez C; Flynn R; Ware CF; Croft M; Salek-Ardakani S
    J Immunol; 2009 May; 182(10):6278-86. PubMed ID: 19414781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.
    Seneschal J; Jiang X; Kupper TS
    J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
    Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
    J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for direct TLR2-MyD88 signaling in CD8 T-cell clonal expansion and memory formation following vaccinia viral infection.
    Quigley M; Martinez J; Huang X; Yang Y
    Blood; 2009 Mar; 113(10):2256-64. PubMed ID: 18948575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens.
    Tan WG; Zubkova I; Kachko A; Wells F; Adler H; Sutter G; Major ME
    PLoS One; 2017; 12(7):e0181578. PubMed ID: 28732046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surprisingly Effective Priming of CD8
    Croft S; Wong YC; Smith SA; Flesch IEA; Tscharke DC
    J Virol; 2020 Sep; 94(20):. PubMed ID: 32759313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term recall of memory CD8 T cells in mice to first and third generation smallpox vaccines.
    Green S; Ennis FA; Mathew A
    Vaccine; 2011 Feb; 29(8):1666-76. PubMed ID: 21195803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization.
    Belyakov IM; Ahlers JD; Nabel GJ; Moss B; Berzofsky JA
    Virology; 2008 Nov; 381(1):106-15. PubMed ID: 18793787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Vaccinia Virus Ankara Can Induce Optimal CD8
    Wong YC; Croft S; Smith SA; Lin LCW; Cukalac T; La Gruta NL; Drexler I; Tscharke DC
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31375596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodomination during peripheral vaccinia virus infection.
    Lin LC; Flesch IE; Tscharke DC
    PLoS Pathog; 2013; 9(4):e1003329. PubMed ID: 23633956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccinia virus CD8+ T-cell dominance hierarchies cannot be altered by prior immunization with individual peptides.
    Wang Y; Flesch IE; Tscharke DC
    J Virol; 2009 Sep; 83(17):9008-12. PubMed ID: 19535449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia).
    Jayakumar A; Castilho TM; Park E; Goldsmith-Pestana K; Blackwell JM; McMahon-Pratt D
    PLoS Negl Trop Dis; 2011 Jun; 5(6):e1204. PubMed ID: 21695103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins.
    Haglund K; Leiner I; Kerksiek K; Buonocore L; Pamer E; Rose JK
    J Virol; 2002 Aug; 76(15):7506-17. PubMed ID: 12097563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells.
    Hovav AH; Panas MW; Osuna CE; Cayabyab MJ; Autissier P; Letvin NL
    J Virol; 2007 Dec; 81(23):12793-802. PubMed ID: 17881444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2.
    Davies ML; Sei JJ; Siciliano NA; Xu RH; Roscoe F; Sigal LJ; Eisenlohr LC; Norbury CC
    J Virol; 2014 Mar; 88(6):3557-67. PubMed ID: 24403581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intradermal immune response after infection with Vaccinia virus.
    Jacobs N; Chen RA; Gubser C; Najarro P; Smith GL
    J Gen Virol; 2006 May; 87(Pt 5):1157-1161. PubMed ID: 16603516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia Virus BBK E3 Ligase Adaptor A55 Targets Importin-Dependent NF-κB Activation and Inhibits CD8
    Pallett MA; Ren H; Zhang RY; Scutts SR; Gonzalez L; Zhu Z; Maluquer de Motes C; Smith GL
    J Virol; 2019 May; 93(10):. PubMed ID: 30814284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OX40 drives protective vaccinia virus-specific CD8 T cells.
    Salek-Ardakani S; Moutaftsi M; Crotty S; Sette A; Croft M
    J Immunol; 2008 Dec; 181(11):7969-76. PubMed ID: 19017988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.